Does BISOPROLOL Cause Salivary hypersecretion? 15 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Salivary hypersecretion have been filed in association with BISOPROLOL (bisoprolol fumarate and hydrochlorothiazide). This represents 0.1% of all adverse event reports for BISOPROLOL.
15
Reports of Salivary hypersecretion with BISOPROLOL
0.1%
of all BISOPROLOL reports
0
Deaths
4
Hospitalizations
How Dangerous Is Salivary hypersecretion From BISOPROLOL?
Of the 15 reports, 4 (26.7%) required hospitalization.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BISOPROLOL. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does BISOPROLOL Cause?
Dyspnoea (2,940)
Bradycardia (2,535)
Hypotension (2,504)
Dizziness (2,153)
Fall (2,011)
Fatigue (1,983)
Acute kidney injury (1,894)
Malaise (1,602)
Drug ineffective (1,486)
Nausea (1,460)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which BISOPROLOL Alternatives Have Lower Salivary hypersecretion Risk?
BISOPROLOL vs BISOPROLOL\BISOPROLOL
BISOPROLOL vs BISOPROLOL\HYDROCHLOROTHIAZIDE
BISOPROLOL vs BIVALIRUDIN
BISOPROLOL vs BLEOMYCIN
BISOPROLOL vs BLINATUMOMAB